Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (701-710 of 706) with videos related to

Pageof 71
Sort By:
You have reached the last page of results.This site can display upto 706 results.
JAMA|September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
Journal of the American College of Cardiology|August 27, 2025
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskPaul M Haller, Giorgio E M Melloni, David D Berg, et al.
JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.
Circulation|November 13, 2020
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic DiseaseNicholas A Marston, Parth N Patel, Frederick K Kamanu, et al.
The New England Journal of Medicine|April 1, 2014
Darapladib for preventing ischemic events in stable coronary heart disease, Harvey D White, Claes Held, et al.
Pageof 71

Showing results (701-710 of 706) with videos related to

Sort By:
Pageof 71
You have reached the last page of results.This site can display upto 706 results.
JAMA|September 1, 2014
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trialMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
Journal of the American College of Cardiology|August 27, 2025
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskPaul M Haller, Giorgio E M Melloni, David D Berg, et al.
JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.
Circulation|November 13, 2020
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic DiseaseNicholas A Marston, Parth N Patel, Frederick K Kamanu, et al.
The New England Journal of Medicine|April 1, 2014
Darapladib for preventing ischemic events in stable coronary heart disease, Harvey D White, Claes Held, et al.
Pageof 71